N. F. Crum and G. Ballon-landa, Coccidioidomycosis in pregnancy: case report and review of the literature, Am J Med, vol.119, pp.993-1004, 2006.

A. W. Chow and P. J. Jewesson, Pharmacokinetics and safety of antimicrobial agents during pregnancy, Rev Infect Dis, vol.7, pp.287-313, 1985.

J. O. Forfar and M. M. Nelson, Epidemiology of drugs taken by pregnant women: drugs that may affect the fetus adversely, Clin Pharmacol Ther, vol.14, pp.632-674, 1973.

M. F. Hebert, X. Ma, and S. B. Naraharisetti, Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice, Clin Pharmacol Ther, vol.85, pp.607-621, 2009.

T. S. Tracy, R. Venkataramanan, and D. D. Glover, Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy, Am J Obstet Gynecol, vol.192, pp.633-642, 2005.

V. V. Moudgal and J. D. Sobel, Antifungal drugs in pregnancy: a review, Expert Opin Drug Saf, vol.2, pp.475-83, 2003.

G. Chaouat, S. Dubanchet, L. , and N. , Cytokines: important for implantation?, J Assist Reprod Genet, vol.24, pp.491-505, 2007.

P. Luppi, How immune mechanisms are affected by pregnancy, Vaccine, vol.21, pp.3352-3359, 2003.

K. D. Priddy, Immunologic adaptations during pregnancy, J Obstet Gynecol Neonatal Nurs, vol.26, pp.388-94, 1997.

J. H. Rowe, J. M. Ertelt, and L. Xin, Pregnancy imprints regulatory memory that sustains anergy to fetal antigen, Nature, vol.490, pp.102-108, 2012.

R. Pouillot, K. Hoelzer, and K. A. Jackson, Relative risk of listeriosis in Foodborne Diseases Active Surveillance Network (FoodNet) sites according to age, pregnancy, and ethnicity, Clin Infect Dis, vol.54, issue.5, pp.405-415, 2012.

C. R. Machado, E. S. Machado, and R. D. Rohloff, Is pregnancy associated with severe dengue? A review of data from the Rio de Janeiro surveillance information system, PLoS Negl Trop Dis, vol.7, p.2217, 2013.

D. J. Jamieson, M. A. Honein, and S. A. Rasmussen, H1N1 2009 influenza virus infection during pregnancy in the USA, Lancet, vol.374, pp.451-459, 2009.

J. D. Sobel, Vulvovaginal candidosis, Lancet, vol.369, pp.1961-71, 2007.

L. E. Smale and J. W. Birsner, Maternal deaths from coccidioidomycosis, J Am Med Assoc, vol.140, pp.1152-1156, 1949.

R. S. Bercovitch, A. Catanzaro, and B. S. Schwartz, Coccidioidomycosis during pregnancy: a review and recommendations for management, Clin Infect Dis, vol.53, pp.363-371, 2011.

V. J. Flaherman, R. Hector, and G. W. Rutherford, Estimating severe coccidioidomycosis in California, Emerg Infect Dis, vol.13, pp.1087-90, 2007.

S. P. Whitt, G. A. Koch, and B. Fender, Histoplasmosis in pregnancy: case series and report of transplacental transmission, Arch Intern Med, vol.164, pp.454-462, 2004.

L. B. Lemos, M. Soofi, and E. Amir, Blastomycosis and pregnancy, Ann Diagn Pathol, vol.6, pp.211-216, 2002.

O. Lortholary, H. Nunez, and M. W. Brauner, Pulmonary cryptococcosis. Semin Respir Crit Care Med, vol.25, pp.145-57, 2004.

G. G. Briggs, R. K. Freeman, and S. J. Yaffe, Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 2011.

N. Sonino, The use of ketoconazole as an inhibitor of steroid production, New Engl J Med, vol.317, pp.812-820, 1987.

R. C. Heel, R. N. Brogden, and C. A. , Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections, Drugs, vol.23, pp.1-36, 1982.

G. M. Tiboni, Second branchial arch anomalies induced by fluconazole, a bis-triazole antifungal agent, in cultured mouse embryos, Res Commun Chem Pathol Pharmacol, vol.79, pp.381-385, 1993.

K. A. Aleck and D. L. Bartley, Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient, Am J Med Genet, vol.72, pp.253-259, 1997.

T. J. Pursley, I. K. Blomquist, and J. Abraham, Fluconazole-induced congenital anomalies in three infants, Clin Infect Dis, vol.22, pp.336-376, 1996.

B. E. Lee, M. Feinberg, and J. J. Abraham, Congenital malformations in an infant born to a woman treated with fluconazole, Pediatr Infect Dis J, vol.11, pp.1062-1066, 1992.

P. Mastroiacovo, T. Mazzone, and L. D. Botto, Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole, Am J Obstet Gynecol, vol.175, pp.1645-50, 1996.

N. Vlachadis, Z. Iliodromiti, and N. Vrachnis, Oral fluconazole during pregnancy and risk of birth defects, New Engl J Med, vol.369, p.2061, 2013.

G. M. Tiboni and F. Giampietro, Murine teratology of fluconazole: evaluation of developmental phase specificity and dose dependence, Pediatr Res, vol.58, pp.94-103, 2005.

E. Menegola, M. L. Broccia, D. Renzo, and F. , Pathogenic pathways in fluconazole-induced branchial arch malformations, Birt Defects Res A Clin Mol Teratol, vol.67, pp.116-140, 2003.

, during pregnancy and the risk of birth defects, New Engl J Med, vol.369, pp.830-839, 2013.

L. M. Bean, J. R. Jackson, and W. J. Dobak, Intra-amniotic fluconazole therapy for Candida albicans intra-amniotic infection, Obstet Gynecol, vol.121, pp.452-456, 2013.

B. Bar-oz, M. E. Moretti, and R. Bishai, Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study, Am J Obstet Gynecol, vol.183, pp.617-637, 2000.

G. M. Tiboni, F. Marotta, D. Corso, and A. , Defining critical periods for itraconazole-induced cleft palate, limb defects and axial skeletal malformations in the mouse, Toxicol Lett, vol.167, pp.8-18, 2006.

M. De-santis, D. Gianantonio, E. Cesari, and E. , First-trimester itraconazole exposure and pregnancy outcome: a prospective cohort study of women contacting teratology information services in Italy, Drug Saf Int J Med Toxicol Drug Exp, vol.32, pp.239-283, 2009.

, Federal Register, vol.44, pp.37434-37441, 1980.

M. Shoai-tehrani, F. S. De-fontbrune, and P. Roth, Exposure to voriconazole in second and third trimesters of pregnancy: a case report, Antimicrob Agents Chemother, vol.57, pp.1094-1099, 2013.

D. Bitar, G. Morizot, and D. Van-cauteren, Estimating the burden of mucormycosis infections in France (2005 -2007) through a capturerecapture method on laboratory and administrative data, Rev Epidemiol Sante Publique, vol.60, pp.383-390, 2012.

, Noxafil Package Insert, 2006.

, Cancidas Package Insert, 2001.

D. Cappelletty and K. Eiselstein-mckitrick, The echinocandins, Pharmacotherapy, vol.27, pp.369-88, 2007.

, Eraxis Package Insert, 2006.

R. B. Diasio, D. E. Lakings, and J. E. Bennett, Evidence for conversion of 5-fluorocytosine to 5-fluorouracil in humans: possible factor in 5-fluorocytosine clinical toxicity, Antimicrob Agents Chemother, vol.14, pp.903-911, 1978.

N. Nutley, Ancobon Package Insert. Roche Laboratories, 2003.

E. W. Ely, J. E. Peacock, and E. F. Haponik, Cryptococcal pneumonia complicating pregnancy, Medicine (Baltimore), vol.77, pp.153-67, 1998.

M. L. Costa, J. P. Souza, O. Neto, and A. F. , Cryptococcal meningitis in HIV negative pregnant women: case report and review of literature, Rev Inst Med Trop São Paulo, vol.51, pp.289-94, 2009.

J. R. Perfect, W. E. Dismukes, and F. Dromer, Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America, Clin Infect Dis, vol.50, pp.291-322, 2010.

M. A. Ismail and S. A. Lerner, Disseminated blastomycosis in a pregnant woman: review of amphotericin B usage during pregnancy, Am Rev Respir Dis, vol.126, pp.350-353, 1982.

H. Hager, S. I. Welt, and J. P. Cardasis, Disseminated blastomycosis in a pregnant woman successfully treated with amphotericin-B. A case report, J Reprod Med, vol.33, pp.485-493, 1988.

, Amphotec Package Insert, 1996.

, AmBisome Package Insert, 1997.

, Abelcet Package Insert, 1996.

M. Mueller, M. Balasegaram, and Y. Koummuki, A comparison of liposomal amphotericin B with sodium stibogluconate for the treatment of visceral leishmaniasis in pregnancy in Sudan, J Antimicrob Chemother, vol.58, pp.811-816, 2006.

P. Pagliano, N. Carannante, and M. Rossi, Visceral leishmaniasis in pregnancy: a case series and a systematic review of the literature, J Antimicrob Chemother, vol.55, pp.229-262, 2005.

E. A. Figueiró--filho, E. Beitune, P. Queiroz, and G. T. , Visceral leishmaniasis and pregnancy: analysis of cases reported in a central-western region of Brazil, Arch Gynecol Obstet, vol.278, pp.13-19, 2008.

, Lamisil Package Insert, 1992.

R. Aly, Ecology and epidemiology of dermatophyte infections, J Am Acad Dermatol, vol.31, pp.21-25, 1994.

A. Rubin and D. Dvornik, Placental transfer of griseofulvin, Am J Obstet Gynecol, vol.92, pp.882-885, 1965.

F. W. Rosa, C. Hernandez, and C. Wa, Griseofulvin teratology, including two thoracopagus conjoined twins, Lancet, vol.1, p.171, 1987.

A. E. Czeizel, J. Mé-tneki, and Z. Kazy, A population-based case -control study of oral griseofulvin treatment during pregnancy, Acta Obstet Gynecol Scand, vol.83, pp.827-858, 2004.

A. E. Czeizel, Z. Kazy, and E. Puhó, Population-based case-control teratologic study of topical miconazole, Congenit Anom, vol.44, pp.41-46, 2004.

A. E. Czeizel, Z. Kazy, and E. Puhó, A population-based case -control teratological study of oral nystatin treatment during pregnancy, Scand J Infect Dis, vol.35, pp.830-835, 2003.

S. Mavrogenis, R. Urban, and A. E. Czeizel, Maternal risk factors in the origin of isolated hypospadias-a population-based case -control study, Congenit Anom, vol.54, pp.110-115, 2014.

W. Mendling and J. Brasch, Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society, Mycoses, vol.55, pp.1-13, 2012.

W. Mendling, C. Krauss, and B. Fladung, A clinical multicenter study comparing efficacy and tolerability of topical combination therapy with clotrimazole (Canesten, two formats) with oral single dose fluconazole (Diflucan) in vulvovaginal mycoses, Mycoses, vol.47, pp.136-178, 2004.

J. Wolff, Iodide goiter and the pharmacologic effects of excess iodide, Am J Med, vol.47, pp.101-125, 1969.

F. Carswell, M. M. Kerr, and J. H. Hutchison, Congenital goitre and hypothyroidism produced by maternal ingestion of iodides, Lancet, vol.1, pp.1241-1244, 1970.

W. C. Plauché, Sporotrichosis in pregnancy, Am J Obstet Gynecol, vol.100, pp.1150-1151, 1968.

M. E. Ghanem, L. A. El-baghdadi, and A. M. Badawy, Pregnancy outcome after renal allograft transplantation: 15 years experience, Eur J Obstet Gynecol Reprod Biol, vol.121, pp.178-81, 2005.

J. R. Harris, S. R. Lockhart, and E. Debess, Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen, Clin Infect Dis, vol.53, pp.1188-95, 2011.

J. N. Galgiani, N. M. Ampel, and J. E. Blair, Clin Infect Dis, vol.41, pp.1217-1240, 2005.

T. J. Walsh, E. J. Anaissie, and D. W. Denning, Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America, Clin Infect Dis, vol.46, pp.327-60, 2008.

S. W. Chapman, W. E. Dismukes, and L. A. Proia, Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America, Clin Infect Dis, vol.46, pp.1801-1813, 2008.

L. J. Wheat, A. G. Freifeld, and M. B. Kleiman, Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America, Clin Infect Dis, vol.45, pp.807-832, 2007.

P. G. Pappas, C. A. Kauffman, and D. Andes, Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America, Clin Infect Dis, vol.48, pp.503-538, 2009.

C. A. Kauffman, B. Bustamante, and S. W. Chapman, Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America, Clin Infect Dis, vol.45, pp.1255-65, 2007.